Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective

Interstitial lung diseases (ILDs) are a large and diverse group of rare and chronic respiratory disorders, with idiopathic pulmonary fibrosis (IPF) being the most common and best-studied member. Increasing interest in fibrosis as a therapeutic target and the appreciation that fibrotic mechanisms may...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Carlo Albera, Giulia Verri, Federico Sciarrone, Elena Sitia, Mauro Mangiapia, Paolo Solidoro
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Subjects:	antifibrotic therapy fibrosis idiopathic pulmonary fibrosis interstitial lung disease nintedanib pirfenidone
Online Access:	https://www.mdpi.com/2227-9059/9/9/1237